Cambridge Consultants is working to develop the next generation of dry powder inhaler for Chiesi Farmaceutici SpA, an emerging European pharmaceutical company based in Parma, Italy. The new inhaler aims to be the easiest-to-use dry powder inhaler on the market. The design incorporates features to improve performance and make the device discreet, intuitive to use and futuristic in appearance.
Cambridge Consultants has created an innovative design taking into account user needs and stringent regulatory requirements.
By applying a broad range of expertise in fluid dynamics, design for manufacture and industrial design combined with in-house analytical testing we have created a breakthrough device.
Features include 'double-dosing' protection and a mechanical dose counter. The device is exceptionally easy to use with feedback from user groups showing an extremely positive response.
We have worked with some of the world's leading manufacturers during the technical transfer stage, validation and production scale-up. We have also supported Chiesi during the build of devices for clinical trials.
"The results that we have received so far from clinical trials and user groups have been truly impressive," said Gaetano Brambilla, R&D Project Leader at Chiesi. "The combination of our innovative drug formulations and Cambridge Consultants' design expertise has resulted in a device that we expect to be very competitive towards the established market leaders."